U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Immunophenotypic Complete Response

MedGen UID:
881440
Concept ID:
C4054737
Finding

Definition

The disappearance of all signs of cancer, supported by the absence of phenotypically aberrant plasma cells (clonal) in bone marrow. (Rajkumar SV, Harousseau J, Durie B et al, Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood. 2011; 117(18):4691-4695) [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVImmunophenotypic Complete Response

Professional guidelines

PubMed

Leon-Ferre RA, Whitaker KR, Suman VJ, Hoskin T, Giridhar KV, Moore RM, Al-Jarrad A, McLaughlin SA, Northfelt DW, Hunt KN, Conners AL, Moyer A, Carter JM, Kalari K, Weinshilboum R, Wang L, Ingle JN, Knutson KL, Ansell SM, Boughey JC, Goetz MP, Villasboas JC
Breast Cancer Res 2024 Jun 10;26(1):97. doi: 10.1186/s13058-024-01848-z. PMID: 38858721Free PMC Article
Bassez A, Vos H, Van Dyck L, Floris G, Arijs I, Desmedt C, Boeckx B, Vanden Bempt M, Nevelsteen I, Lambein K, Punie K, Neven P, Garg AD, Wildiers H, Qian J, Smeets A, Lambrechts D
Nat Med 2021 May;27(5):820-832. Epub 2021 May 6 doi: 10.1038/s41591-021-01323-8. PMID: 33958794
Robak T
Cancer Treat Rev 2011 Feb;37(1):3-10. Epub 2010 Jun 16 doi: 10.1016/j.ctrv.2010.05.003. PMID: 20558005

Recent clinical studies

Etiology

Fukumoto K, Fujisawa M, Suehara Y, Narita KT, Usui Y, Takeuchi M, Matsue K
Leuk Lymphoma 2016 Aug;57(8):1786-92. Epub 2016 Jan 13 doi: 10.3109/10428194.2015.1121262. PMID: 26764045
Mateos MV, Oriol A, Martínez-López J, Teruel AI, López de la Guía A, López J, Bengoechea E, Pérez M, Martínez R, Palomera L, de Arriba F, González Y, Hernández JM, Granell M, Bello JL, Bargay J, Peñalver FJ, Martín-Mateos ML, Paiva B, Montalbán MA, Bladé J, Lahuerta JJ, San-Miguel JF
Blood 2014 Sep 18;124(12):1887-93. doi: 10.1182/blood-2014-05-573733. PMID: 25102853

Therapy

Fukumoto K, Fujisawa M, Suehara Y, Narita KT, Usui Y, Takeuchi M, Matsue K
Leuk Lymphoma 2016 Aug;57(8):1786-92. Epub 2016 Jan 13 doi: 10.3109/10428194.2015.1121262. PMID: 26764045
Mateos MV, Oriol A, Martínez-López J, Teruel AI, López de la Guía A, López J, Bengoechea E, Pérez M, Martínez R, Palomera L, de Arriba F, González Y, Hernández JM, Granell M, Bello JL, Bargay J, Peñalver FJ, Martín-Mateos ML, Paiva B, Montalbán MA, Bladé J, Lahuerta JJ, San-Miguel JF
Blood 2014 Sep 18;124(12):1887-93. doi: 10.1182/blood-2014-05-573733. PMID: 25102853

Prognosis

Fukumoto K, Fujisawa M, Suehara Y, Narita KT, Usui Y, Takeuchi M, Matsue K
Leuk Lymphoma 2016 Aug;57(8):1786-92. Epub 2016 Jan 13 doi: 10.3109/10428194.2015.1121262. PMID: 26764045
Mateos MV, Oriol A, Martínez-López J, Teruel AI, López de la Guía A, López J, Bengoechea E, Pérez M, Martínez R, Palomera L, de Arriba F, González Y, Hernández JM, Granell M, Bello JL, Bargay J, Peñalver FJ, Martín-Mateos ML, Paiva B, Montalbán MA, Bladé J, Lahuerta JJ, San-Miguel JF
Blood 2014 Sep 18;124(12):1887-93. doi: 10.1182/blood-2014-05-573733. PMID: 25102853

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...